# Gain Therapeutics, Inc.: Form 8-K, filed Jan 15, 2025

- Company: [Gain Therapeutics, Inc.](/companies/ganx.md) (CIK 1819411)
- Form: 8-K
- Filed: 2025-01-15
- Accepted by EDGAR: Jan 15, 2025, 17:00 ET
- Period: 2025-01-08
- Accession: 0001104659-25-003801
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1819411/000110465925003801/tm253348d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1819411/000110465925003801/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1819411/000110465925003801/tm253348d1_8k.htm

Filed Jan 15, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-003801. Last ingested by Listed: Nov 11, 2026, 00:31 ET. No prices; not investment advice.